Silo Pharma Closes Private Placement, Expects About $815,000 in Net Proceeds

• Silo Pharma closed a private placement on Nov. 6, 2026, with expected net proceeds of approximately $815,000.
• Purchase agreements dated Nov. 5, 2026, covered 136,005 common shares at $1.50 per share.
• The placement also included pre-funded warrants to purchase 430,661 common shares at $1.4999 per warrant.
• The pre-funded warrants are immediately exercisable at $0.0001 per share.
• Net proceeds are intended for working capital and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-116982), on November 06, 2026, and is solely responsible for the information contained therein.